Analytic Investors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Analytic Investors’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-95,102	Closed	-$1.04M	–	704
2016 Q1	$1.04M	Buy	95,102 +14,872	+19%	+$188K	0.01%	396
2015 Q4	$1.39M	Buy	80,230 +13,048	+19%	+$234K	0.02%	347
2015 Q3	$1.33M	Sell	67,182 -19,767	-23%	-$453K	0.02%	330
2015 Q2	$1.43M	Sell	86,949 -6,192	-7%	-$107K	0.02%	321
2015 Q1	$1.45M	Buy	93,141 +71,385	+328%	+$1.11M	0.02%	313
2014 Q4	$311K	Buy	+21,756	New	+$230K	﹤0.01%	472
2014 Q1	–	Sell	-20,520	Closed	-$193K	–	639
2013 Q4	$193K	Buy	+20,520	New	+$146K	﹤0.01%	476

Other funds holding SCMP

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Analytic Investors's SCMP Position: Q2 2016 in Review

Analytic Investors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2016, closing a stake of 95,102 shares — an estimated $1.04M sold.

Analytic Investors first reported a position in SCMP in Q4 2013 and held it in 7 quarters. The position peaked at $1.45M in Q1 2015. 136 funds tracked by Wall St. Rank hold SCMP as of Q2 2016.

Analytic Investors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Analytic Investors sold 95,102 Sucampo Pharmaceuticals, Inc. shares in Q2 2016, an estimated $1.04M.
Analytic Investors first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2013 and held it in 7 quarters.
Analytic Investors's Sucampo Pharmaceuticals, Inc. position peaked at $1.45M in Q1 2015.
136 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2016.

Based on Analytic Investors's 13F filing for Q2 2016, filed 11 Aug 2016.